S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

Koninklijke DSM Stock Forecast, Price & News

+0.69 (+1.92%)
(As of 07/1/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
48,783 shs
Average Volume
66,705 shs
Market Capitalization
$25.62 billion
P/E Ratio
Dividend Yield
Price Target

Koninklijke DSM Stock Forecast (MarketRank)

Analyst Rating
Moderate Buy
2.80 Rating Score
385.8% Upside
$178.00 Price Target
Short Interest
0.01% of Shares Sold Short
Dividend Strength
Based on Four Factors
News Sentiment
-0.01mentions of Koninklijke DSM in the last 14 days
Based on 5 Articles This Week
Insider Trading
Proj. Earnings Growth
From $1.36 to $1.49 Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

1.77 out of 5 stars

30 days | 90 days | 365 days | Advanced Chart

Receive RDSMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Koninklijke DSM and its competitors with MarketBeat's FREE daily newsletter.

Koninklijke DSM logo

About Koninklijke DSM (OTCMKTS:RDSMY)

Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, premixes, carotenoids, enzymes, microbes, and eubiotics; human nutrition and health products comprising vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics, and prebiotics, as well as active pharmaceutical ingredients; premix, market-ready solutions, and personalized nutrition; human milk oligosaccharides; and skin and sun care, hair care, and aroma ingredients; omega-3 fatty acids; and specialty food enzymes, cultures, bio-preservation, texturizing hydrocolloids, sugar reduction, and savory taste solutions. The Materials segment provides specialty plastics used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries; and Dyneema, a fiber solution for use in personal protection, workwear, sports apparel, outdoor equipment, ropes and slings, synthetic chains, and nets for the aquaculture, and renewable energy sectors. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, continence care, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, peripheral vascular, plastic and reconstructive surgery, and wound management. It also commercializes yeast technology yeast for ethanol production. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.

RDSMY Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Chemicals & allied products
Current Symbol
Previous Symbol
Year Founded

Company Calendar

Last Earnings
Ex-Dividend for 6/10 Dividend
Dividend Payable
Fiscal Year End

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecasted Upside/Downside
Consensus Rating
Moderate Buy
Rating Score (0-4)
Research Coverage
10 Analysts


Pretax Margin


Sales & Book Value

Annual Sales
$10.89 billion
Cash Flow
$2.30 per share
Book Value
$11.78 per share


Free Float
Market Cap
$25.62 billion
Not Optionable

Koninklijke DSM Frequently Asked Questions

Should I buy or sell Koninklijke DSM stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Koninklijke DSM in the last year. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" Koninklijke DSM stock.
View analyst ratings for Koninklijke DSM
or view top-rated stocks.

What is Koninklijke DSM's stock price forecast for 2022?

10 Wall Street analysts have issued 12 month price targets for Koninklijke DSM's shares. Their RDSMY stock forecasts range from $155.00 to $188.00. On average, they anticipate Koninklijke DSM's stock price to reach $178.00 in the next year. This suggests a possible upside of 385.8% from the stock's current price.
View analysts' price targets for Koninklijke DSM
or view top-rated stocks among Wall Street analysts.

How has Koninklijke DSM's stock performed in 2022?

Koninklijke DSM's stock was trading at $56.61 at the beginning of 2022. Since then, RDSMY shares have decreased by 35.3% and is now trading at $36.64.
View the best growth stocks for 2022 here

Are investors shorting Koninklijke DSM?

Koninklijke DSM saw a increase in short interest during the month of June. As of June 15th, there was short interest totaling 35,600 shares, an increase of 256.0% from the May 31st total of 10,000 shares. Based on an average daily volume of 129,400 shares, the short-interest ratio is currently 0.3 days.
View Koninklijke DSM's Short Interest

How were Koninklijke DSM's earnings last quarter?

Koninklijke DSM (OTCMKTS:RDSMY) announced its quarterly earnings results on Tuesday, November, 3rd. The basic materials company reported $0.30 EPS for the quarter, missing the consensus estimate of $0.31 by $0.01. The basic materials company earned $2.29 billion during the quarter.
View Koninklijke DSM's earnings history

How often does Koninklijke DSM pay dividends? What is the dividend yield for Koninklijke DSM?

Koninklijke DSM declared a dividend on Friday, May 13th. Investors of record on Monday, May 16th will be given a dividend of $0.3593 per share on Friday, June 10th. This represents a yield of 1.5%. The ex-dividend date of this dividend is Friday, May 13th.
View Koninklijke DSM's dividend history

Is Koninklijke DSM a good dividend stock?

Koninklijke DSM(OTCMKTS:RDSMY) pays an annual dividend of $0.73 per share and currently has a dividend yield of 2.03%.
View Koninklijke DSM's dividend history.

Who are Koninklijke DSM's key executives?

Koninklijke DSM's management team includes the following people:
  • Mr. Dimitri de Vreeze, Co-CEO, COO & Member of the Managing Board (Age 55, Pay $2.13M)
  • Ms. Geraldine Matchett, Co-CEO, CFO, Member of the Managing Board & Acting EVP of People & Organization (Age 50, Pay $2.07M)
  • Mr. Dave Huizing, VP of Investor Relations
  • Ms. Lieke de Jong-Tops, Sr. Communications Mang.
  • Mr. Rob J. Atsma, Head of Energie Beheer Nederland (Age 76)
  • Mr. Paul Gilgen, Head of Manufacturing & Purchasing of DSM Nutritional Products (Age 77)
  • Mr. Manfred Eggersdorfer, Sr. VP of Nutrition Science & Advocacy (Age 71)
  • Mr. Bruno Müller, Head of Strategy & VITAL Project - Nutritional Products (Age 66)
  • Mr. Jan Wolters, Head of Fine Chemicals (Age 79)
  • Mr. Luca Rosetto, Sr. VP of Operations - Nutritional Products (Age 59)

What is Koninklijke DSM's stock symbol?

Koninklijke DSM trades on the OTCMKTS under the ticker symbol "RDSMY."

How do I buy shares of Koninklijke DSM?

Shares of RDSMY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Koninklijke DSM's stock price today?

One share of RDSMY stock can currently be purchased for approximately $36.64.

How much money does Koninklijke DSM make?

Koninklijke DSM (OTCMKTS:RDSMY) has a market capitalization of $25.62 billion and generates $10.89 billion in revenue each year.

How many employees does Koninklijke DSM have?

Koninklijke DSM employs 21,358 workers across the globe.

How can I contact Koninklijke DSM?

Koninklijke DSM's mailing address is Het Overloon 1, Heerlrn P7, 6411 TE. The official website for Koninklijke DSM is www.dsm.com. The basic materials company can be reached via phone at (145) 578-8111 or via fax at 31-45-571-9753.

This page (OTCMKTS:RDSMY) was last updated on 7/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.